Clemastine Treatment in Individuals With Williams Syndrome
NCT06087757
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
30
Enrollment
OTHER_GOV
Sponsor class
Conditions
Williams Syndrome
Interventions
DRUG:
Open Label Clemastine with a blinded randomize withdrawal
Sponsor
Sheba Medical Center
Collaborators
[object Object]